Adverse effects of proton pump inhibitors among Indians - A retrospective study
Bioinformation · 31.10.2026 · 22 (10) · 6924-6930
DOI: 10.6026/973206300226924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Surabhi Divyangini Ghanashree.
Abstract (Originalsprache)
The long-term use of Proton pump inhibitor (PPI) is common. However there is little evidence on its association with haematological and biochemical abnormalities among South Indian people. This retrospective observational study included 100 adults (60 PPI users and 40 matched non-users). We evaluated thrombocytopenia, anaemia, serum iron and ferritin and magnesium levels. Thrombocytopenia was significantly more prevalent among PPI users than non-users (53.3% vs. serum ferritin was significantly lower (41.75 vs. 144.25 ng/mL, p=0.001), while serum iron was higher (72.30 vs. 53.78 mcg/dL, p=0.005) in PPI users. PPI duration was negatively correlated with Haemoglobin (r=−0.49), serum iron (r=−0.27) and ferritin (r=−0.41) and no associations were found between anaemia and hypomagnesaemia. Thus, chronic use of a PPI is associated with thrombocytopenia and low iron stores, so it should be monitored regularly while taking this medication for a long period.
Zitieren
APA
Ghanashree, S. D. (2026). Adverse effects of proton pump inhibitors among Indians - A retrospective study. Bioinformation, 22(10), 6924-6930. https://doi.org/10.6026/973206300226924
Vancouver
Ghanashree SD. Adverse effects of proton pump inhibitors among Indians - A retrospective study. Bioinformation. 2026;22(10):6924-6930. doi:10.6026/973206300226924
BibTeX
@article{Ghanashree2026,
author = {Ghanashree, Surabhi Divyangini},
title = {Adverse effects of proton pump inhibitors among Indians - A retrospective study},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {6924--6930},
doi = {10.6026/973206300226924}
}
EUVIMED